# OnCo record meningioma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/meningioma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "meningioma" ;
  schema:name "Meningioma"@en ;
  schema:alternateName "Meningeal tumour"@en, "Atypical meningioma"@en, "Anaplastic meningioma"@en, "Malignant meningioma"@en ;
  schema:description "Meningiomas grow from the membranes covering the brain and spinal cord rather than from the brain itself. Most are slow and benign and are either watched or removed; radiotherapy or radiosurgery treats what surgery cannot reach or what grows back, and no drug has yet been approved for them."@en ;
  schema:url <https://onco.cc/cancers/meningioma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Meningioma> ;
  schema:citation <https://en.wikipedia.org/wiki/Meningioma>, <https://doi.org/10.1093/neuonc/noab150> ;
  onco:tag "subtype-page", "cns" ;
  onco:related <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/vestibular-schwannoma/>, <https://onco.cc/cancers/spinal-cord-tumours/> ;
  onco:technologies <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/gamma-knife/>, <https://onco.cc/technologies/cyberknife/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/methylation-profiling/>, <https://onco.cc/technologies/prrt/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/technologies/mri/> ;
  onco:targets <https://onco.cc/targets/mtor/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/everolimus/> ;
  onco:terms <https://onco.cc/terms/stereotactic-radiosurgery/> ;
  onco:pipeline <https://onco.cc/technologies/prrt/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:standardOfCare <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/methylation-profiling/>, <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/gamma-knife/>, <https://onco.cc/technologies/cyberknife/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/technologies/prrt/> .